Clinical Trials Sponsored by Icagen
Total 1993 results
-
IcagenCompletedSickle Cell Disease | Sickle Cell AnemiaUnited States
-
IcagenCompletedAtopic AsthmaUnited Kingdom
-
IcagenCompletedExercise Induced AsthmaUnited States
-
OcugenNot yet recruitingDiabetic Macular Edema | Center Involved Diabetic Macular Edema
-
OcugenRecruiting
-
OcugenRecruitingRetinitis Pigmentosa | Leber Congenital AmaurosisUnited States
-
OcugenTerminatedGraft vs Host Disease | Ocular Surface Disease | Graft Versus Host Disease | Ocular Graft vs Host Disease | Ophthalmic Solutions | oGVHD | Brimonidine Tartrate | Lubricant Eye DropsUnited States
-
OcugenRecruitingStargardt DiseaseUnited States
-
OcugenNo longer available
-
OcugenRecruitingGeographic AtrophyUnited States
-
OcugenCompleted
-
IcagenJohnson & Johnson Pharmaceutical Research & Development, L.L.C.TerminatedSickle Cell Disease | Sickle Cell AnemiaUnited States
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell LungUnited States, Belgium, Poland, Spain, Hungary, France
-
Seagen Inc.RecruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Gastric Cancer | Ovarian Neoplasms | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Neoplasms | Esophageal Squamous Cell CarcinomaUnited States, Spain, Italy, Canada, United Kingdom, France, Belgium, Germany, Netherlands
-
Seagen Inc.RecruitingAcute Myeloid Leukemia | Myelodyspastic SyndromeUnited States, Netherlands
-
Seagen Inc.Active, not recruitingPeripheral T-cell LymphomaUnited States, Czechia, Italy, Spain, United Kingdom, France
-
Inogen Inc.CompletedNocturnal HypoxemiaUnited States
-
Inogen Inc.CompletedHeart FailureCanada
-
Seagen Inc.Terminated
-
Seagen Inc.Active, not recruitingUrologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Carcinoma, Non-Small-Cell Lung | Biliary Tract Neoplasms | HER2 Mutations Breast NeoplasmsUnited States, United Kingdom, Spain, Korea, Republic of, Italy, Belgium, Germany, Japan, Netherlands, Poland
-
Seagen Inc.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Korea, Republic of, United Kingdom, Taiwan, Canada, Australia
-
Seagen Inc.CompletedHER2 Positive Breast CancersUnited States, Canada
-
Seagen Inc.TerminatedMultiple MyelomaUnited States
-
Seagen Inc.TerminatedCarcinoma, Renal Cell | Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Carcinoma, Squamous Cell of Head and Neck | Urinary Bladder NeoplasmUnited States
-
Seagen Inc.Completed
-
Seagen Inc.TerminatedDiffuse, Large B-Cell, Lymphoma | Follicular Lymphoma, Grade 3b | Transformed Lymphoma / DLBCLUnited States, Puerto Rico
-
Seagen Inc.TerminatedMyelodysplastic SyndromeUnited States
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Seagen Inc.TerminatedSystemic Lupus ErythematosusUnited States
-
Tocagen Inc.CompletedGlioblastoma | Anaplastic Oligoastrocytoma | Anaplastic Astrocytoma | Anaplastic OligodendrogliomaUnited States
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States
-
Seagen Inc.CompletedBurkitt Lymphoma | Precursor B-cell Lymphoblastic Leukemia-LymphomaUnited States
-
Seagen Inc.CompletedLymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, T-CellUnited States, Canada
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Solid Tumors | Acute Lymphoid Leukemia | Anemia, Refractory, With Excess of BlastsUnited States
-
Seagen Inc.CompletedLymphoma, Non-Hodgkin | Carcinoma, Renal CellUnited States
-
Seagen Inc.TerminatedBreast CancerUnited States
-
Seagen Inc.CompletedCarcinoma, Non-Small-Cell LungUnited States
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Hodgkin Disease | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Squamous Cell Carcinoma of the Head and Neck | Pancreatic Ductal AdenocarcinomaUnited States
-
Seagen Inc.RecruitingUrothelial CarcinomaUnited States, France
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Adenoid Cystic Carcinoma | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Endometrial Neoplasms | Cholangiocarcinoma | Triple Negative Breast Neoplasms | Gallbladder Carcinoma | HER2 Negative Breast Neoplasms | Hormone Receptor Positive Breast NeoplasmsUnited States, Spain, Canada, United Kingdom, Germany, Italy
-
Seagen Inc.RecruitingGastric Adenocarcinoma | Cholangiocarcinoma | Esophageal Adenocarcinoma | Colorectal Carcinoma | Gallbladder Carcinoma | GEJ AdenocarcinomaUnited States, Japan
-
Seagen Inc.Active, not recruitingDiffuse Large B-cell LymphomaUnited States, France, Australia, Czechia, Italy, Spain, Canada, Belgium, Korea, Republic of, United Kingdom, Poland, Denmark, Germany, Netherlands, Switzerland, Taiwan
-
Seagen Inc.TerminatedUterine Cervical Neoplasms | Stomach Neoplasms | Testicular Neoplasms | Carcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Endometrial Neoplasms | Gastroesophageal Junction CarcinomaUnited States, Canada, Spain, Sweden, United Kingdom
-
Seagen Inc.CompletedHER2 Positive Breast CancerUnited States, Spain, Belgium, Germany, Israel, France, United Kingdom, Austria, Denmark, Italy, Australia, Canada, Czechia, Portugal, Switzerland